Analytical Services Center for Medications Development Program
Award Notice Posted
- Solicitation number
- 75N98026D00031
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Mriglobal
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N98026D00031-75N98026F00001_75N98026F00002 Federal IDV award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Bethesda, Maryland, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute on Drug Abuse awarded Contract No. 75N98026D00031 to MRIGlobal for the Analytical Services Center for Medications Development Program on July 17, 2026, with an award value of $5 million.
The contract includes an anticipated five-year period of performance and will use a Cost Plus Fixed Fee and Firm Fixed Price basis with task orders. The award followed unrestricted competition; no set-aside was applied.
Notice text
NOTICE OF AWARD. THIS IS NOT A REQUEST FOR QUOTE/PROPOSALS.
On July 17, 2022; in response to the requirements of Solicitation 75N95024R00032, the National Institute on Drug Abuse (NIDA) awarded Contract No. 75N98026D00031 to MRIGlobal for the Analytical Services Center for Medications Development . NIDA anticipates the use of Task Orders with an ultimate Period of Performance of five (5) years. An award shall be made on a Cost Plus Fixed Fee and Firm Fixed Price basis.
Awarded contract 75N98026D00031 to MRIGLOBAL for 5000000.00 on 2026-07-17.
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Analytical Services Center for Medications Development Program | Solicitation | |
| Analytical Services Center for Medications Development Program | Pre-Solicitation | |
| Analytical Services Center for Medications Development Program | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | No set-aside | |
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | Total Small Business | |
| Best Pharmaceuticals for Children Act Data Coordination Center | National Institute of Child Health and Human Development | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity